Episodic hemorrhage during honeybee venom anaphylaxis: Potential mechanisms

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 4, 2012, Pages 237-244

  Mingomataj, Ervin Ç ^a,b   Bakiri, A H ^c  

^a Mother Theresa School of Medicine   (Albania)

^b UNIVERSITY OF TIRANA   (Albania)

^c Faculty of Medical Sciences   (Albania)

Author keywords

Anaphylaxis; Bradykinin system; Hemorrhage; Honeybee venom; Melittin. metrorrhagia

Indexed keywords

BEE VENOM; BRADYKININ; COMPLEMENT; ESTROGEN; HYALURONIDASE; MELITTIN; PHOSPHOLIPASE A2;

ANAPHYLAXIS; BEE STING; BLEEDING; BLOOD CLOT LYSIS; BLOOD CLOTTING; ENDOMETRIAL BLEEDING; ENDOMETRIAL DISEASE; EPISODIC HEMORRHAGE; HEMOLYSIS; HUMAN; IMMUNOTHERAPY; MAST CELL DEGRANULATION; METRORRHAGIA; NONHUMAN; PATHOGENESIS; REVIEW; SMOOTH MUSCLE TONE; THROMBOCYTE AGGREGATION INHIBITION; UTERUS BLEEDING; UTERUS CONTRACTION;

ANAPHYLAXIS; ANIMALS; BEE VENOMS; BEES; BITES AND STINGS; BRADYKININ; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; INSECT BITES AND STINGS; MELITTEN; METRORRHAGIA; UTERUS;

EID: 84863316291     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Lam SM. Acute pulmonary hemorrhage following a honeybee sting: a case report. J Microbiol Immunol Infect. 1998;31:133-6.
2. Bilo MB, Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy. 2009;39:1467-76.
3. Müller UR. [Insect venom allergy]. Ther Umsch 1994;51:38-44. German.
4. Reisman RE. Unusual reactions to insect stings. Curr Opin Allergy Clin Immunol. 2005;5:355-8.
5. Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN; EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy. 2005;60:1339-49.
6. Demain JG, Minaei AA, Tracy JM. Anaphylaxis and insect allergy. Curr Opin Allergy Clin Immunol. 2010;10:318-22.
7. Alcoceba E, Marquès L, Lara S. Metrorrhagia in anaphylactic reactions. Allergy. 2009;64(Suppl 90):214.
8. Toubi E, Kessel A, Golan TD. Vaginal bleeding - a rare complication of immunotherapy. Allergy. 1997;52:782-3.
9. Gonzalo-Garijo MA, Pérez-Rangel I, Alvarado-Izquierdo MI, Pérez-Calderón R, Sánchez-Vega S, Zambonino MA. Metrorrhagia as an uncommon symptom of anaphylaxis. J Invest Allergol Clin Immunol. 2010;20:540-1.
10. Frank DE. Metrorrhagia due to allergy to cold. Ann Allergy. 1947;5:574.
11. Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010;152:S161-81.
12. Remes-Troche JM, Téllez-Zenteno JF, Rojas-Serrano J, Senties- Madrid H, Vega-Boada F, García-Ramos G. Thalamic and mesencephalic hemorrhages after multiple honeybee stings: a life-threatening apitherapy complication. Eur Neurol. 2003;49:188-9.
13. Müller UR. Insect venoms. Chem Immunol Allergy. 2010;95:141-56.
14. Mingomataj EÇ, Bakiri A. The inhibition of kallikrein-bradykinin pathway may be useful in the reduction of allergic reactions during honeybee venom immunotherapy. Irn J Med Hypotheses Ideas. 2009;3:10.
15. Mingomataj EÇ, Ohri D, Dhimitri V, Priftanji A, Qirko E, Pani L, Fischer TC, Dinh QT, Peiser C, Fischer A, Groneberg DA. Hymenoptera sting anaphylactic reactions in the Mediterranean population of Albania. J Invest Allergol Clin Immunol. 2003;13:272-7.
16. Binder M, Fierlbeck G, King T, Valent P, Bühring HJ. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/ phosphodiesterase 3 (CD203c) in sensitized patients. Int Arch Allergy Immunol. 2002;129:160-8.
17. Gauldie J, Hanson JM, Rumjanek FD, Shipolini RA, Vernon CA. The peptide components of bee venom. Eur J Biochem. 1976;61:369-76.
18. Kaplan AP. Kinins, airway obstruction, and anaphylaxis. Chem Immunol Allergy. 2010;95:67-84.
19. Da Silva A, Amrani Y, Trifilieff A, Landry Y. Involvement of B2 receptors in the bradykinin-induced relaxation of guinea-pig isolated trachea. Br J Pharmacol. 1995;114:103-8.
20. Joseph K, Kaplan AP. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol. 2005;86:159-208.
21. Iwaki T, Castellino FJ. Plasma levels of bradykinin are suppressed in factor XII-deficient mice. Thromb Haemost. 2006;95:1003-10.
22. Nishimura K, Alhenc-Gelas F, White A, Erdös EG. Activation of membrane-bound kallikrein and renin in the kidney. Proc Natl Acad Sci U S A. 1980;77:4975-8.
23. Schmaier AH. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system. Int Immunopharmacol. 2008;8:161-5.
24. Murphey LJ, Malave HA, Petro J, Biaggioni I, Byrne DW, Vaughan DE, Luther JM, Pretorius M, Brown NJ. Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans. J Pharmacol Exp Ther. 2006;318:1287-92.
25. Cleary DB, Ehringer WD, Maurer MC. Establishing the inhibitory effects of bradykinin on thrombin. Arch Biochem Biophys. 2003;410:96-106.
26. Landmesser U, Drexler H. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide. J Hypertens Suppl. 2006;24:S39-43.
27. Gryglewski RJ, Uracz W, Chopicki S, Marcinkiewicz E. Bradykinin as a major endogenous regulator of endothelial function. Pediatr Pathol Mol Med. 2002;21:279-90.
28. Wojewódzka-Zelezniakowicz M, Stankiewicz A, Malinowska- Zaprzałka M, Chabielska E. [The influence of tissue and plasma angiotensin converting enzyme inhibitors on haemostasis with respect to experimental and clinical investigations]. Kardiol Pol. 2005;63(4 Suppl 2):S420-7. Polish.
29. Pretorius M, Rosenbaum D, Vaughan DE, Brown NJ. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. Circulation. 2003;107:579-85.
30. Gryglewski RJ, Swies J, Uracz W, Chopicki S, Marcinkiewicz E. Mechanisms of angiotensin-converting enzyme inhibitor induced thrombolysis in Wistar rats. Thromb Res. 2003;110:323-9.
31. Labinjoh C, Newby DE, Pellegrini MP, Johnston NR, Boon NA, Webb DJ. Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition. J Am Coll Cardiol. 2001;38:1402-8.
32. Felmeden DC, Lip GY. The renin-angiotensin-aldosterone system and fibrinolysis. J Renin Angiotensin Aldosterone Syst. 2000;1:240-4.
33. Prado M, Solano-Trejos G, Lomonte B. Acute physiopathological effects of honeybee (Apis mellifera) envenoming by subcutaneous route in a mouse model. Toxicon. 2010;56:1007-17.
34. DeGrado WF, Musso GF, Lieber M, Kaiser ET, Kézdy FJ. Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue. Biophys J. 1982;37:329-38.
35. Rudenko SV, Bojok GA, Nipot EE. Bee venom-induced shrinkage of erythrocyte ghosts. Biochemistry (Mosc). 1997;62:104-9.
36. van den Bogaart G, Guzmán JV, Mika JT, Poolman B. On the mechanism of pore formation by melittin. J Biol Chem. 2008;283:33854-7.
37. Dragoviæ T, Igiæ R, Erdös EG, Rabito SF. Metabolism of bradykinin by peptidases in the lung. Am Rev Respir Dis. 1993;147:1491-6.
38. Maher S, Feighery L, Brayden DJ, McClean S. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae. Pharm Res. 2007;24:1346-56.
39. Lawson LD, Powell DW. Bradykinin-stimulated eicosanoid synthesis and secretion by rabbit ileal components. Am J Physiol. 1987;252:G783-90.
40. Sciani JM, Marques-Porto R, Lourenço Junior A, Orsi Rde O, Ferreira Junior RS, Barraviera B, Pimenta DC. Identification of a novel melittin isoform from Africanized Apis mellifera venom. Peptides. 2010;31:1473-9.
41. Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit. 2001;7:1075-85.
42. Naderali EK, Poyser NL. Factors controlling prostaglandin production by guinea-pig endometrial cells. J Reprod Fertil. 1996;108:321-8.
43. Graf GA, Burns PD, Silvia WJ. Expression of a cytosolic phospholipase A2 by ovine endometrium on days 11-14 of a simulated oestrous cycle. J Reprod Fertil. 1999;115:357-63.
44. Cameron IT, Leask R, Kelly RW, Baird DT. Endometrial prostaglandins in women with abnormal menstrual bleeding. Prostaglandins Leukot Med. 1987;29:249-57.
45. Sheppard BL. The pathology of dysfunctional uterine bleeding. Clin Obstet Gynaecol. 1984;11:227-36.
46. Ailamazyan EK, Petrishchev NN, Vivulanets EV, Maryutina LV, Mindukshev IV, Khachaturyan AR. Effects of oxytocin and prostaglandin F(2alpha) (enzaprost) on platelet aggregation. Bull Exp Biol Med. 2002;134:439-41.
47. Milovanov AP, Kirsanov IaN. [The pathogenesis of uterine hemorrhages in the so-called placental polyps]. Arkh Patol. 2008;70:34-7. Russian.
48. Vijapurkar M, Mota L, Shetty S, Ghosh K. Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent. Haemophilia. 2009;15:199-202.
49. Ferenczy A. Pathophysiology of endometrial bleeding. Maturitas. 2003;45:1-14.
50. Gilabert-Estelles J, Ramon LA, España F, Gilabert J, Castello R, Estelles A. Expression of the fibrinolytic components in endometriosis. Pathophysiol Haemost Thromb. 2006;35:136-40.
51. Gaetje R, Scharl A, Kaufmann M, Ahr A. [Management of abnormal uterine bleeding]. Zentralbl Gynakol. 2006;128:196-201. German.
52. Yang XP, Carretero OA, Jacobsen G, Scicli AG. Role of endogenous brain kinins in the cardiovascular response to intracerebroventricular melittin. Hypertension. 1989;14:629-35.
53. Yalcin M, Savci V. Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms. Neuropeptides. 2007;41:465-75.
54. Amfilochiadis AA, Backx PH, Floras JS. Adrenomedullary catecholamine, pressor and chronotropic responses to human coagulation beta-FXIIa mediated by endogenous kinins. J Hypertens. 2008;26:61-9.
55. Amfilochiadis AA, Papageorgiou PC, Kogan N, Boomsma F, Osmond DH. Role of bradykinin B2-receptor in the sympathoadrenal effects of 'new pressor protein' related to human blood coagulation factor XII fragment. J Hypertens. 2004;22:1173-81.
56. Mingomataj E, Priftanji A, Qirko E, Dinh QT, Fischer A, Peiser C, Groneberg DA. Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venom. BMC Dermatology. 2002;2:11.
57. Lindsberg PJ, Strbian D, Karjalainen-Lindsberg ML. Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab. 2010;30:689-702.
58. Levine S, Saltzman A. Petechial hemorrhages in the small intestinal Peyer's patches: a new manifestation of systemic anaphylaxis. Immunol Invest. 1998;27:135-44.
59. Binder M, Fierlbeck G, King T, Valent P, Bühring HJ. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/ phosphodiesterase 3 (CD203c) in sensitized patients. Int Arch Allergy Immunol. 2002;129:160-8.
60. Noble SJ, Armstrong PJ. Bee sting envenomation resulting in secondary immune-mediated hemolytic anemia in two dogs. J Am Vet Med Assoc. 1999;214:1026-7.
61. Soldatova LN, Crameri R, Gmachl M, Kemeny DM, Schmidt M, Weber M, Mueller UR. Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli. J Allergy Clin Immunol. 1998;101:691-8.
62. Kreil G. Hyaluronidases--a group of neglected enzymes. Protein Sci. 1995;4:1666-9.
63. Tan NH, Ponnudurai G. Comparative study of the enzymatic, hemorrhagic, procoagulant and anticoagulant activities of some animal venoms. Comp Biochem Physiol C. 1992;103:299-302.
64. Isman F, Kucur M, Tanriverdi T, Kacira T, Sanus GZ, Kemerdere R, Hanimoglu H, Kaynar MY. Serum hyaluronidase levels in patients with aneurysmal subarachnoid haemorrhage. Singapore Med J. 2008;49:405-9.
65. Kuppermann BD, Thomas EL, de Smet MD, Grillone LR; Vitrase for Vitreous Hemorrhage Study Groups. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol. 2005;140:585-97.
66. Gandini S, Panicucci F. [Cutaneous iontophoresis of hyaluronidase in the treatment of hemorrhages in hemophilic patients]. Electrodiagn Ther. 1977;14:99-105. French.
67. Chen W, Mempel M, Schober W, Behrendt H, Ring J. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy. 2008;63:1418-27.
68. Duan QL, Binkley K, Rouleau GA. Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogendependent inherited angioedema. J Allergy Clin Immunol. 2009;123:906-10.
69. Heinman M. The role of stress situations and psychological factors in functional uterine bleeding. J Mt Sinai Hosp N Y. 1956;23:775-81.
70. Ben-Shoshan M, Clarke AE. Anaphylaxis: past, present and future. Allergy. 2011;66:1-14.
71. Neuman I, Ishay JS, Creter D. Hyperreactivity to bee stings: reevaluation. Ann Allergy. 1983;50:410-2.
72. Müller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, Blaser K. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol. 1998;101:747-54.
73. Mingomataj EÇ, Bakiri A. Insights on perspectives of hymenoptera venom immunotherapy. In: Gjersoe J, Hundstad S, editors. Venoms: sources, toxicity and therapeutic uses. Nova Science Publishers Inc.; 2010. p. 1-28.